Wong J H, Gupta R K, Morton D L
John Wayne Cancer Clinic, Armand Hammer Laboratories, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90024.
J Surg Oncol. 1988 Jul;38(3):147-50. doi: 10.1002/jso.2930380304.
We have isolated and characterized a melanoma tumor-associated antigen (TAA) from the spent culture medium of a melanoma cell line. Its presence has been detected in 72% of different melanoma specimens but not in normal tissues. Because tumor antigens may stimulate or perhaps block immune reactions to cancer cells, their presence on the cell surface may be a critical factor influencing tumor growth. Therefore, to define further the immunobiological characteristics of melanoma TAA, this antigen was investigated by membrane immunofluorescence. Serum from a melanoma patient known to have a high anti-TAA antibody titer was absorbed quantitatively with lymphoblastoid cells autologous to the target melanoma cells to remove non-anti-TAA antibodies. The absorbed serum was reacted with three cultured melanoma cell lines, UCLA-SO-10 (M10), UCLA-SO-14(M), and UCLA-SO-24 (M24). Of these cell lines, M10 and M14 are known to express the antigen as assessed by radioimmunoassay. Reaction of the antibody(s) to the antigen(s) on the melanoma cell surface was detected by fluorescein-conjugated goat anti-human IgG. The reactivity of the absorbed serum was inhibited by preincubation with purified melanoma TAA. These results clearly demonstrate that melanoma TAA is expressed on the cell surface of cultured melanoma cells.
我们从一种黑色素瘤细胞系的培养上清液中分离并鉴定了一种黑色素瘤肿瘤相关抗原(TAA)。在72%的不同黑色素瘤标本中检测到了它的存在,但在正常组织中未检测到。由于肿瘤抗原可能刺激或也许阻断对癌细胞的免疫反应,它们在细胞表面的存在可能是影响肿瘤生长的关键因素。因此,为了进一步确定黑色素瘤TAA的免疫生物学特性,通过膜免疫荧光法对这种抗原进行了研究。用与目标黑色素瘤细胞自体的淋巴母细胞对已知具有高抗TAA抗体滴度的黑色素瘤患者的血清进行定量吸收,以去除非抗TAA抗体。将吸收后的血清与三种培养的黑色素瘤细胞系UCLA - SO - 10(M10)、UCLA - SO - 14(M)和UCLA - SO - 24(M24)反应。在这些细胞系中,通过放射免疫测定法评估已知M10和M14表达该抗原。通过荧光素偶联的山羊抗人IgG检测抗体与黑色素瘤细胞表面抗原的反应。用纯化的黑色素瘤TAA预孵育可抑制吸收后血清的反应性。这些结果清楚地表明,黑色素瘤TAA在培养的黑色素瘤细胞表面表达。